PSX vs TERN · P/E 17, rev $143.15B vs $6.12B cap
Phillips 66 (PSX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PSX currently screens at market cap $67.02B and trailing P/E 16.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PSX and TERN stock pages for the full models.
Not investment advice.